CN100406043C

CN100406043C - A Chinese medicinal composition for treating prostatitis

Info

Publication number: CN100406043C
Application number: CNB200610019075XA
Authority: CN
Inventors: 曾桥生
Original assignee: Individual
Current assignee: Individual
Priority date: 2006-05-13
Filing date: 2006-05-13
Publication date: 2008-07-30
Anticipated expiration: 2026-05-13
Also published as: CN1879763A

Abstract

The present invention relates to a traditional Chinese medicine composition for treating prostatitis, which belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition for treating prostatitis is prepared from raw material medicines of the following weight percent: 16 to 53% of thorny elaeagnus root, 15 to 46% of christina loosestrife, 9 to 33% of rush pith and 10 to 42% of plantain herb. The sum of the weight percents of each raw material is 100%. After decoction or oral liquid or granules prepared from the medicine of the present invention is taken through oral administration, effective components in the raw material medicines can quickly penetrate through prostate films, and thus, the medicine can quickly perform the functions of blood activation, blood stasis dissipation, heat elimination, diuresis promotion, dephlogistication, pain alleviation and urination promotion by treating stranguria; thus, pathogenic bacteria are killed, the inflammation is eliminated, and the total effective rate reaches 94.6%.

Description

The prostatitic Chinese medicine composition of a kind of treatment

Technical field

The present invention relates to the prostatitic Chinese medicine composition of a kind of treatment, belong to technical field of Chinese medicines.

Background technology

Prostatitis is the common a kind of disease of adult male reproduction, and the person between twenty and fifty at 30～45 years old of mostly occurring adopt usually: conventional therapies such as heat-clearing and toxic substances removing, kidney invigorating and YANG supporting, blood circulation promoting and blood stasis dispelling, diuresis are not turbid.A large amount of prior aries is arranged at this problem, for example: application number 200410084422, denomination of invention " a kind of treatment prostatitis Chinese medicine preparation ", form by following raw materials according: the Radix Rehmanniae, the Rhizoma Anemarrhenae, Cortex Phellodendri, Herba Ecliptae, Fructus Ligustri Lucidi, Herba Plantaginis, Radix Paeoniae Rubra, the present invention can improve the prostate blood circulation, suppress pathogenic microorganism growth in the prostate effectively, obviously eliminate the chronic prostatitis clinical symptoms, advantages such as having determined curative effect, shorten the course of treatment, improve cure rate, reduce relapse rate, side effect is little.However, still do not have specific medicament for the treatment prostatitis in the prior art, the curative effect of its medicine has much room for improvement.

Summary of the invention

Therefore, still there is demand in people for the Chinese medicine composition that the treatment prostatitis has better curative effect.Up to the present, do not find to destroy the data of novelty of the present invention as yet, present inventor people has collected a large amount of clinical observation materials by clinical practice, has obtained the treatment prostatitis is had the Chinese medicine composition of better curative effect, thereby has finished the present invention.

Purpose of the present invention is exactly that a kind of prostatitic Chinese medicine composition of treatment with better curative effect will be provided.

The present invention is achieved in that it is made by following raw material medicines in percentage by weight: Radix Elaeagni 16%-53%, Herba Lysimachiae 15%-46%, Medulla Junci 9%-33% and Herba Plantaginis 10%-42%, the percentage by weight sum of each raw material is 100%.

Be preferably: made by following raw material medicines in percentage by weight: Radix Elaeagni 20%-45%, Herba Lysimachiae 15%-40%, Medulla Junci 10%-28% and Herba Plantaginis 10%-32%, the percentage by weight sum of each raw material is 100%.

More preferably: make: Radix Elaeagni 33.3% Herba Lysimachiae 33.3%, Medulla Junci 16.7% and Herba Plantaginis 16.7% by following raw material medicines in percentage by weight.Can add wick and make guiding drug.

Preparation technology of the present invention meets new Chinese medicine preparation technology's specification requirement in principle, uses modern preparation new technique, becomes various decoctions, oral liquid or electuary etc. with the crude drug combined preparation.By doctor's advice oral after, effective ingredient in the crude drug can quick penetration prostate film, gets the effect of blood circulation promoting and blood stasis dispelling, clearing away heat-damp and promoting diuresis, anti-inflammatory analgetic, diuresis promoting rapidly, reaches the therapeutic purposes that degerm is eliminated inflammation.

The specific embodiment

The present invention is described further by clinical observation and embodiment.

The clinical observation on the therapeutic effect data

1, clinical physical data:

Receive smelting patient 296 examples altogether, wherein the age: 29 examples below 30 years old, 30～35 years old 43 example, 35～45 years old 162 example, 62 examples more than 45 years old; The oldest 75 years old, minimum 22 years old of age; Unmarried 52 examples, married 244 examples, before the treatment course of disease 6 months with interior 44 examples, 6～12 months 153 examples, 12～18 months 62 examples, 37 examples more than 18 months.

2, diagnostic criteria:

(1), clinically mainly show as: frequent micturition, urgent micturition, dysurea, paruria, it is scratchy that the urine meaning reaches urethra not to the utmost; After an action of the bowels droplet satellite, drip whitely, urethral orifice has haircuts, liquid, there is the pain of degree not at the anus position and weighs down the sense of expanding, testis distending pain, pudendum distending pain, waist are ached etc.; Sexual impotence, premature ejaculation are waited until sexual dysfunction.

(2), examination of prostatic fluid, lecithin reduces, leukocyte greater than 10 or pus cell "+" above/every high power field.

3, Therapeutic Method: according to prostatitic etiology and pathogenesis, be base side, the crude drug compositions is obtained decoction by traditional middle drug-decocting method with the present invention.Oral, about 26～60 grams of primary material drug composition consumption, one day secondary (look the state of an illness, follow the doctor's advice), ten days is a course of treatment, reaches rehabilitation effect 1～3 course of treatment substantially, again 1～2 course of treatment of after treatment, can reach the clinical cure effect.

4, efficacy assessment standard:

Recovery from illness: clinical symptom disappearance, under every high power field, leukocyte is lower than below 10, and it is normal that lecithin recovers.

Produce effects: clinical symptoms alleviates substantially or obviously, and gland liquid is conventional near normal, and prostate does not have obvious tenderness.

Take a turn for the better: subjective symptoms disappear or significantly alleviate, no tenderness, the more preceding obvious minimizing of the conventional leukocyte number of gland liquid, lecithin increase or normal substantially.

Invalid: 3 of medications are more than the course of treatment, and symptom does not have obvious improvement; Each index does not have obvious change.

5, therapeutic outcome:

By the conventional therapy of 1～3 course of treatment, can improve clinical symptoms rapidly: recovery from illness: 92 examples, account for 31.1%, produce effects: 103 examples, account for 34.8%, take a turn for the better: 72 examples, account for 24.3%, invalid: as 29 examples, to account for 9.8%; Total effective rate 90.2%.

Through 1～2 after treatment course of treatment, clinical symptoms rapidly disappears, body constitution recovers normal again; Recovery from illness: 142 examples, account for 48%, produce effects 74 examples, account for 25%, 64 examples that take a turn for the better, account for 21.6%, invalid 16 examples, account for 5.4%; Total effective rate 94.6%.

Made by following raw material medicines in percentage by weight among the embodiment: Radix Elaeagni 16%-53%, Herba Lysimachiae 15%-46%, Medulla Junci 9%-33% and Herba Plantaginis 10%-42%, the percentage by weight sum of each raw material is 100%, all has curative effect.

Be preferably: Radix Elaeagni 20%-45%, Herba Lysimachiae 15%-40%, Medulla Junci 10%-28% and Herba Plantaginis 10%-32%, the percentage by weight sum of each raw material is 100%, curative effect is better.

Embodiment 1:

Take off and state each composition raw materials by weight percent medicine and make: Radix Elaeagni 33.3%, Herba Lysimachiae 33.3%, Medulla Junci 16.7% and Herba Plantaginis 16.7%.

Embodiment 2: take off and state each composition raw materials by weight percent medicine and make: Radix Elaeagni 21%, Herba Lysimachiae 39.5%, Medulla Junci 26.3% and Herba Plantaginis 13.2%.

Embodiment 3: take off and state each composition raw materials by weight percent medicine and make: Radix Elaeagni 41.6%, Herba Lysimachiae 16.6%, Medulla Junci 10.5%, Herba Plantaginis 31.3%.

Embodiment 4: take off and state each composition raw materials by weight percent medicine and make: Radix Elaeagni 40%, Herba Lysimachiae 30%, Medulla Junci, 20% and Herba Plantaginis 10%.

Embodiment 5: take off and state each composition raw materials by weight percent medicine and make: Radix Elaeagni 26.3%, Herba Lysimachiae 31.5%, Medulla Junci 21.1% and Herba Plantaginis 21.1%.

Embodiment 6: take off and state each composition raw materials by weight percent medicine and make: Radix Elaeagni 37.7%, Herba Lysimachiae 15.1%, Medulla Junci 18.9% and Herba Plantaginis 28.3%.

Embodiment 7: take off and state each composition raw materials by weight percent medicine and make: Radix Elaeagni 53%, Herba Lysimachiae 25%, Medulla Junci 9% and Herba Plantaginis 13%.

All can add wick in the embodiment of the invention and make guiding drug.

Claims

1. treat prostatitic Chinese medicine composition for one kind, it is characterized in that it is made by following raw material medicines in percentage by weight: Radix Elaeagni 16%-53%, Herba Lysimachiae 15%-46%, Medulla Junci 9%-33% and Herba Plantaginis 10%-42%, the percentage by weight sum of each raw material is 100%.

2. the prostatitic Chinese medicine composition of a kind of treatment according to claim 1, it is characterized in that it is made by following raw material medicines in percentage by weight: Radix Elaeagni 20%-45%, Herba Lysimachiae 15%-40%, Medulla Junci 10%-28% and Herba Plantaginis 10%-32%, the percentage by weight sum of each raw material is 100%.

3. the prostatitic Chinese medicine composition of a kind of treatment according to claim 1 and 2 is characterized in that it is made by following raw material medicines in percentage by weight: Radix Elaeagni 33.3%, Herba Lysimachiae 33.3%, Medulla Junci 16.7% and Herba Plantaginis 16.7%.